Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Bristol-Myers Squibb presents in vivo results on new Trk inhibitors

Aug. 29, 2012

Jakavi approved in Europe

Aug. 29, 2012

MORAb-004 enters new phase II trial

Aug. 28, 2012

Novel candidate cancer drugs presented

Aug. 28, 2012

French team designs novel antiangiogenic agents

Aug. 28, 2012

Seattle Genetics kicks off new study in renal cell carcinoma

Aug. 27, 2012

New everolimus formulation approved in Japan

Aug. 27, 2012

Novartis reports new mTOR/PI3K inhibitors

Aug. 27, 2012

New inhibitors of V600E-mutant B-raf presented

Aug. 27, 2012

PCI Biotech selects next indication for Amphinex

Aug. 24, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...